Trial Profile
Phase II trial of KPI 10 in patients with bacterial infections.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 11 Sep 2012
Price :
$35
*
At a glance
- Drugs KPI 10 (Primary)
- Indications Bacterial infections
- Focus Therapeutic Use
- Sponsors Kalidex Pharmaceuticals
- 11 Sep 2012 Planned initiation date changed from 1 Jun 2012 to 1 Jun 2013.
- 11 Sep 2012 New trial record